Standout Papers
Immediate Impact
69 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
2024 Standout
Works of Heather E. Reese being referenced
Use of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022
2022 Standout
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heather E. Reese | 203 | 296 | 51 | 115 | 22 | 611 | |
| James A. Fuller | 267 | 144 | 124 | 69 | 25 | 651 | |
| Sania Ashraf | 345 | 191 | 145 | 46 | 45 | 738 | |
| Grace Malenga | 252 | 93 | 126 | 20 | 14 | 650 | |
| Dietrich Plaß | 30 | 145 | 15 | 71 | 19 | 634 | |
| Saheed Gidado | 56 | 155 | 21 | 60 | 24 | 581 | |
| Heather McKay | 78 | 134 | 23 | 111 | 24 | 675 | |
| Karen L. Peterson | 57 | 92 | 40 | 53 | 25 | 564 | |
| Modupe O. Coker | 74 | 117 | 50 | 17 | 42 | 531 | |
| William Bazeyo | 46 | 147 | 69 | 26 | 38 | 634 | |
| Hannah E. Reses | 40 | 213 | 4 | 40 | 26 | 514 |
All Works
Login with ORCID to disown or claim papers
Loading papers...